Caliper Life Sciences has announced a non-exclusive OEM agreement with Access Genetics to market Caliper's Labchip GX microfluidic system for molecular diagnostic applications.
As part of the agreement, Access Genetics will incorporate web-based software, materials and protocols that the company developed specifically for use with the Labchip GX and market the combined platform's benefits to clinicians, pathologists and physicians.
Caliper's Labchip GX system is an advanced automated electrophoresis instrument that utilises microfluidics chip-based technology to provide high-resolution nucleic acid analysis.
The Labchip GX is said to provide laboratories offering DNA diagnostic testing a platform for automating numerous molecular tests on a common instrument system.
